Orion’s Innovation Hits Blockbuster Status with Bayer for Jointly Developed Prostrate Cancer Drug
Bayer announced that September 2024 in-market sales of Nubeqa® (Darolutamide), the prostrate cancer drug, has exceeded sales of €1 billion year-to-date making Darolutamide the first ever...